Evidence map›Paper›PMID 36417854›Full record

ArticleCell reports2022

Defining the spatial-molecular map of fibrotic tendon healing and the drivers of Scleraxis-lineage cell fate and function.

Jessica E Ackerman, Katherine T Best, Samantha N Muscat, Elizabeth M Pritchett, Anne E C Nichols, Chia-Lung Wu, Alayna E Loiselle

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Increased scleraxis expression is associated with ligamentum flavum hypertrophy in patients with lumbar spinal canal stenosis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  2. Article
  3. Grafts in tendon repair.Materials today. Bio · 2026
    Review
  4. The cellular basis of fibrotic tendon healing: now in higher definition.American journal of physiology. Cell physiology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Spatial transcriptomic applications in orthopedics.Connective tissue research · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Achilles tendinopathy.Nature reviews. Disease primers · 2025
    Review
  18. Loss ofMatrix biology plus · 2025
    Article
  19. Fluoroquinolone-Mediated Tendinopathy and Tendon Rupture.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jessica E AckermanCenter for Musculoskeletal Research, Department of Orthopedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Pathology, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
Katherine T BestCenter for Musculoskeletal Research, Department of Orthopedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Pathology, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
Samantha N MuscatCenter for Musculoskeletal Research, Department of Orthopedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Pathology, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
Elizabeth M PritchettGenomics Research Center, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.
Anne E C NicholsCenter for Musculoskeletal Research, Department of Orthopedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, USA.
Chia-Lung WuCenter for Musculoskeletal Research, Department of Orthopedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, USA.
Alayna E LoiselleCenter for Musculoskeletal Research, Department of Orthopedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Pathology, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA. Electronic address: alayna_loiselle@urmc.rochester.edu.
University of Rochester Medical Center · USUniversity of Rochester · US

Funding

Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Modulating Cell-fate to Promote Regenerative Tendon HealingR01AR077527 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2021 to 2025
$2.0M
s100a4 Signaling in Fibrotic Diabetic Tendon HealingR01AR073169 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2018 to 2022
$1.7M
Epigenetic Regulation of Chondrogenesis and Cartilage DevelopmentR00AR075899 · NIAMS · UNIVERSITY OF ROCHESTER · PI WU, CHIA-LUNG · 2021 to 2023
$1.1M
Epitenon-derived progenitor cells in tendon healing and adaptationK99AR080757 · NIAMS · UNIVERSITY OF ROCHESTER · PI NICHOLS, ANNE E.C. · 2022 to 2023
$283k
Myofibroblast mediated mechanisms of fibrotic tendon healingF31AR077398 · NIAMS · UNIVERSITY OF ROCHESTER · PI ACKERMAN, JESSICA EVE · 2020 to 2021
$92k
Cell Specific Effects of Canonical NF-κB Signaling in Tendon HealingF31AR074815 · NIAMS · UNIVERSITY OF ROCHESTER · PI BEST, KATHERINE T · 2019 to 2019
$45k
NIAMS NIH HHS F31 AR074815NIAMS NIH HHS F31 AR077398NIAMS NIH HHS K99 AR080757NIAMS NIH HHS P30 AR069655NIAMS NIH HHS R00 AR075899NIAMS NIH HHS R01 AR073169NIAMS NIH HHS R01 AR077527
6 · The paper itself

Abstract

Tendon injuries heal via a scar-mediated response, and there are no biological approaches to promote more regenerative healing. Mouse flexor tendons heal through the formation of spatially distinct tissue areas: a highly aligned tissue bridge between the native tendon stubs that is enriched for adult Scleraxis-lineage cells and a disorganized outer shell associated with peri-tendinous scar formation. However, the specific molecular programs that underpin these spatially distinct tissue profiles are poorly defined. In the present study, we combine lineage tracing of adult Scleraxis-lineage cells with spatial transcriptomic profiling to define the overarching molecular programs that govern tendon healing and cell-fate decisions. Pseudotime analysis identified three fibroblast trajectories (synthetic, fibrotic, and reactive) and key transcription factors regulating these fate-switching decisions, including the progression of adult Scleraxis-lineage cells through the reactive trajectory. Collectively, this resource defines the molecular mechanisms that coordinate the temporo-spatial healing phenotype, which can be leveraged to inform therapeutic candidate selection.

Indexed as

CicatrixTendonsAnimalsCell DifferentiationFibroblastsMiceWound HealingCP: Cell biologyfibrosismyofibroblastScleraxisspatial transcriptomicstendon

Identifiers

PMID36417854
PMCPMC9741867
OpenAlexW4309679460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.